OTCMKTS:NEPH - Nephros Stock Price, Price Target & More

$0.59 +0.02 (+3.42 %)
(As of 04/19/2018 04:00 PM ET)
Previous Close$0.5705
Today's Range$0.5493 - $0.59
52-Week Range$0.1810 - $0.6499
Volume59,449 shs
Average Volume51,835 shs
Market Capitalization$30.90 million
P/E Ratio-11.80
Dividend YieldN/A
Beta0.02

About Nephros (OTCMKTS:NEPH)

Nephros, Inc., a commercial stage medical device and commercial product company, develops and sells liquid purification filters and hemodiafiltration (HDF) systems primarily in the United States. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It offers HDF systems for use in conjunction with a hemodialysis machine that enables nephrologists to provide HDF treatment to patients with end stage renal disease; and hemodiafilters for use as dialyzers in an hemodialysis treatment, as well as other disposables for use in the hemodiafiltration treatment process. The company was founded in 1997 and is headquartered in South Orange, New Jersey.

Receive NEPH News and Ratings via Email

Sign-up to receive the latest news and ratings for NEPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:NEPH
CUSIPN/A
Phone201-343-5202

Debt

Debt-to-Equity Ratio0.49%
Current Ratio2.03%
Quick Ratio1.67%

Price-To-Earnings

Trailing P/E Ratio-11.80
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.81 million
Price / Sales8.86
Cash FlowN/A
Price / CashN/A
Book Value$0.04 per share
Price / Book14.75

Profitability

EPS (Most Recent Fiscal Year)($0.05)
Net Income$-800,000.00
Net Margins-21.24%
Return on Equity-238.35%
Return on Assets-74.71%

Miscellaneous

Employees15
Outstanding Shares57,220,000

How to Become a New Pot Stock Millionaire

Nephros (OTCMKTS:NEPH) Frequently Asked Questions

What is Nephros' stock symbol?

Nephros trades on the OTCMKTS under the ticker symbol "NEPH."

How were Nephros' earnings last quarter?

Nephros (OTCMKTS:NEPH) released its quarterly earnings results on Monday, February, 26th. The company reported ($0.01) EPS for the quarter. The business earned $1.30 million during the quarter. Nephros had a negative net margin of 21.24% and a negative return on equity of 238.35%. View Nephros' Earnings History.

When is Nephros' next earnings date?

Nephros is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for Nephros.

Who are some of Nephros' key competitors?

Who are Nephros' key executives?

Nephros' management team includes the folowing people:
  • Mr. Daron G. Evans, Pres, CEO & Director (Age 44)
  • Mr. Andrew Astor, Chief Financial Officer (Age 61)
  • Ms. Joleen C. Turner, VP of Marketing and VP of Bus. Devel.
  • Mr. Shane Sullivan, Director of North American Sales
  • Ms. Monet Carnahan RN, BSN,CDN, Director of Dialysis Products

Has Nephros been receiving favorable news coverage?

Media headlines about NEPH stock have been trending somewhat positive on Thursday, Accern reports. Accern identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Nephros earned a media sentiment score of 0.12 on Accern's scale. They also assigned press coverage about the company an impact score of 47.74 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Nephros' major shareholders?

Nephros' stock is owned by many different of retail and institutional investors. Top institutional shareholders include PESSIN NORMAN H (4.30%). Company insiders that own Nephros stock include Andrew Astor and Daron Evans. View Institutional Ownership Trends for Nephros.

How do I buy shares of Nephros?

Shares of NEPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nephros' stock price today?

One share of NEPH stock can currently be purchased for approximately $0.59.

How big of a company is Nephros?

Nephros has a market capitalization of $30.90 million and generates $3.81 million in revenue each year. The company earns $-800,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis. Nephros employs 15 workers across the globe.

How can I contact Nephros?

Nephros' mailing address is 380 LACKAWANNA PLACE, SOUTH ORANGE NJ, 07079. The company can be reached via phone at 201-343-5202.


MarketBeat Community Rating for Nephros (NEPH)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  69
MarketBeat's community ratings are surveys of what our community members think about Nephros and other stocks. Vote "Outperform" if you believe NEPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEPH will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Nephros (OTCMKTS:NEPH) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 4/19/2016 forward)

Earnings

Nephros (OTCMKTS:NEPH) Earnings History and Estimates Chart

Earnings by Quarter for Nephros (OTCMKTS:NEPH)

Nephros (OTCMKTS:NEPH) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.02 EPS

Nephros (OTCMKTS NEPH) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/8/2018        
2/26/2018Q4 2017($0.01)$1.30 millionViewN/AView Earnings Details
11/9/2017Q3 2017($0.01)$0.92 millionViewN/AView Earnings Details
8/8/2017Q2 2017($0.01)$0.86 millionViewN/AView Earnings Details
5/9/2017Q1 2017($0.01)$0.73 millionViewN/AView Earnings Details
3/20/2017Q4 2016($0.01)$0.75 millionViewN/AView Earnings Details
8/8/2016Q3 2016($0.01)$0.51 millionViewN/AView Earnings Details
5/11/2016Q1 2016($0.02)$0.59 millionViewN/AView Earnings Details
3/30/2016Q4 2015($0.02)$0.51 millionViewN/AView Earnings Details
11/10/2015Q3 2015($0.02)$0.32 millionViewN/AView Earnings Details
8/10/2015Q2 2015($0.06)$0.57 millionViewN/AView Earnings Details
5/15/2015Q1 2015($0.02)$0.54 millionViewN/AView Earnings Details
4/15/2015Q4 2014($0.22)$0.34 millionViewN/AView Earnings Details
11/14/2014Q3 2014($0.03)$0.49 millionViewN/AView Earnings Details
8/14/2014Q2 2014($0.03)$0.44 millionViewN/AView Earnings Details
5/14/2014Q1 2014($0.04)$0.47 millionViewN/AView Earnings Details
3/28/2014Q4 2013($0.07)$0.23 millionViewN/AView Earnings Details
11/14/2013Q3 2013($0.03)$0.42 millionViewN/AView Earnings Details
8/13/2013Q2 2013($0.05)$0.58 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.10)$0.52 millionViewN/AView Earnings Details
3/4/2013Q4 2012($0.09)ViewN/AView Earnings Details
11/8/2012Q3 2012($0.07)ViewN/AView Earnings Details
8/14/2012Q2 2012($0.07)ViewN/AView Earnings Details
5/15/2012Q1 2012($0.05)ViewN/AView Earnings Details
3/22/2012Q4 2011($0.06)ViewN/AView Earnings Details
11/14/2011Q3 2011($0.04)ViewN/AView Earnings Details
8/15/2011Q2 2011($0.06)ViewN/AView Earnings Details
5/16/2011Q1 2011($0.17)ViewN/AView Earnings Details
3/29/2011Q4 2010($0.90)ViewN/AView Earnings Details
11/12/2010Q3 2010($0.20)ViewN/AView Earnings Details
8/16/2010Q2 2010($0.20)ViewN/AView Earnings Details
5/13/2010Q1 2010($0.20)ViewN/AView Earnings Details
4/2/2010Q4 2009($0.22)ViewN/AView Earnings Details
11/12/2009Q3 2009($0.20)ViewN/AView Earnings Details
8/14/2009Q2 2009($0.20)ViewN/AView Earnings Details
3/31/2008Q4 2007($17.00)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Nephros (OTCMKTS:NEPH) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Nephros (OTCMKTS NEPH) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.00%
Insider Trading History for Nephros (OTCMKTS:NEPH)

Nephros (OTCMKTS NEPH) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/10/2018Andrew AstorCFOBuy80,000$0.45$36,000.00View SEC Filing  
4/10/2018Daron EvansInsiderBuy79,000$0.45$35,550.00View SEC Filing  
3/9/2018Andrew AstorCFOBuy5,000$0.48$2,400.00View SEC Filing  
12/4/2017Andrew AstorCFOBuy18,333$0.50$9,166.50View SEC Filing  
9/6/2017Daron EvansInsiderBuy29,580$0.24$7,099.20View SEC Filing  
8/28/2017Andrew AstorCFOBuy10,000$0.27$2,700.00186,709View SEC Filing  
8/22/2017Daron EvansInsiderBuy4,000$0.25$1,000.00View SEC Filing  
8/11/2017Andrew AstorCFOBuy20,000$0.26$5,200.00186,666View SEC Filing  
8/11/2017Daron EvansInsiderBuy70,000$0.26$18,200.00View SEC Filing  
6/9/2017Daron EvansInsiderBuy21,461$0.26$5,579.86View SEC Filing  
5/19/2017Daron EvansInsiderBuy30,000$0.26$7,800.00View SEC Filing  
12/7/2016Daron EvansInsiderBuy4,069$0.32$1,302.08339,428View SEC Filing  
12/5/2016Daron EvansInsiderBuy10,620$0.34$3,610.80329,339View SEC Filing  
12/1/2016Daron EvansInsiderBuy41,530$0.32$13,289.60284,140View SEC Filing  
8/31/2015Daron EvansCEOBuy44,175$0.57$25,179.75169,759View SEC Filing  
8/20/2015Daron EvansCEOBuy51,500$0.53$27,295.00125,584View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Nephros (OTCMKTS NEPH) News Headlines

Source:
DateHeadline
Rounds Report: Nephros To Profit From Industry Tailwinds While Improving FDA Policy To Benefit Patients And InvestorsRounds Report: Nephros To Profit From Industry Tailwinds While Improving FDA Policy To Benefit Patients And Investors
seekingalpha.com - April 19 at 3:52 PM
Insider Buying: Nephros, Inc. (NEPH) Insider Purchases 79,000 Shares of StockInsider Buying: Nephros, Inc. (NEPH) Insider Purchases 79,000 Shares of Stock
www.americanbankingnews.com - April 12 at 7:35 PM
Nephros, Inc. (NEPH) CFO Andrew Astor Buys 80,000 SharesNephros, Inc. (NEPH) CFO Andrew Astor Buys 80,000 Shares
www.americanbankingnews.com - April 12 at 7:35 PM
Nephros announces $2.9M private placementNephros announces $2.9M private placement
seekingalpha.com - April 11 at 11:01 AM
Nephros Announces $2.9 Million Private PlacementNephros Announces $2.9 Million Private Placement
finance.yahoo.com - April 11 at 11:01 AM
Form 424B3 NEPHROS INCForm 424B3 NEPHROS INC
www.streetinsider.com - April 5 at 3:45 PM
Nephros, Inc. to Post FY2018 Earnings of ($0.02) Per Share, Seethru Equity Forecasts (NEPH)Nephros, Inc. to Post FY2018 Earnings of ($0.02) Per Share, Seethru Equity Forecasts (NEPH)
www.americanbankingnews.com - March 8 at 9:08 AM
SeeThruEquity Issues Update on Nephros (NEPH) with Target Price of $1.80SeeThruEquity Issues Update on Nephros (NEPH) with Target Price of $1.80
finance.yahoo.com - March 5 at 11:03 AM
Nephros to Present at NobleCon14Nephros to Present at NobleCon14
finance.yahoo.com - January 23 at 9:07 AM
Nephros Announces Preliminary Financial Results for Fourth Quarter 2017Nephros Announces Preliminary Financial Results for Fourth Quarter 2017
finance.yahoo.com - January 4 at 9:47 AM
Nephros Receives $1.8 Million in Cash from Sale of Tax CreditsNephros Receives $1.8 Million in Cash from Sale of Tax Credits
finance.yahoo.com - December 13 at 10:08 AM
Nephros CFO to Present at the 10th Annual LD Micro Main EventNephros CFO to Present at the 10th Annual LD Micro Main Event
finance.yahoo.com - December 4 at 9:50 AM
ValuEngine Downgrades Nephros (NEPH) to SellValuEngine Downgrades Nephros (NEPH) to Sell
www.americanbankingnews.com - December 3 at 12:40 AM
Nephros, Inc. :NEPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Nephros, Inc. :NEPH-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 9:57 AM
Nephros Inc. (NEPH) Expected to Post FY2017 Earnings of ($0.05) Per ShareNephros Inc. (NEPH) Expected to Post FY2017 Earnings of ($0.05) Per Share
www.americanbankingnews.com - November 17 at 8:30 PM
SeeThruEquity Issues Update on Nephros, Inc. (NEPH)SeeThruEquity Issues Update on Nephros, Inc. (NEPH)
finance.yahoo.com - November 15 at 6:41 AM

SEC Filings

Nephros (OTCMKTS:NEPH) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Nephros (OTCMKTS NEPH) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.